Intra-cellular therapies q1 loss per share $0.73

Intra-cellular therapies reports first quarter 2020 financial results and provides corporate update.q1 loss per share $0.73.q1 earnings per share estimate $-0.93 -- refinitiv ibes data.qtrly total revenues $1.1 million.cash, cash equivalents, restricted cash and investment securities totaled $450.4 million at march 31, 2020.

ITCI Ratings Summary

ITCI Quant Ranking